Amy Hauck Newman

USPTO Granted Patents = 18 (Patent Applications = 3)

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 100(Granted Patents)

Location History:

Silver Spring, MD (US) (1993 - 1997)
Phoenix, AZ (US) (2018)
Phoenix, MD (US) (1998 - 2023)

Company Filing History:

13 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

3 out of 188

University of North Texas

patents

2 out of 1,217

The United States of America As Represented by the Department of Health

patents

4. 2 out of 8,686

US Government As Represented by the Secretary of the Army

patents

where one patent can have more than one assignee

Years Active: 1993-2025

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12479838 - D3 receptor agonist compounds; methods of preparation; intermediates thereof; and methods of use thereof (2025-11-25),

2. 12162861 - Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof (2024-12-10),

3. 12097196 - Dopamine D3 receptor selective antagonists/partial agonists and uses thereof (2024-09-24),

4. 11555013 - Potent and selective inhibitors of monoamine transporters; method of making; and use thereof (2023-01-17),

5. 11365195 - Atypical inhibitors of monoamine transporters; method of making; and use thereof (2022-06-21),

6. 11337971 - Dopamine D3 receptor selective antagonists/partial agonists and uses thereof (2022-05-24),

7. 11299476 - Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof (2022-04-12),

8. 10913711 - Potent and selective inhibitors of monoamine transporters; method of making; and use thereof (2021-02-09),

9. 10590074 - Potent and selective inhibitors of monoamine transporters; method of making; and use thereof (2020-03-17),

10. 9862679 - Potent and selective inhibitors of monoamine transporters; method of making; and use thereof (2018-01-09),

11. 8748608 - [object Object] (2014-06-10),

12. 8383817 - Benztropine compounds and uses thereof (2013-02-26),

13. 8119642 - Structurally rigid dopamine D3 receptor selective ligands and process for making them (2012-02-21),

14. 7605259 - Structurally rigid dopamine d3 receptor selective ligands and process for making them (2009-10-20),

15. 5792775 - 4' and 4', 4'-substituted-3-.alpha.-(diphenylmethoxy) tropane analogs as (1998-08-11),

Title: **Innovative Contributions of Amy Hauck Newman in Neuroscience**

Introduction

Amy Hauck Newman, a prominent inventor based in Phoenix, MD, is recognized for her groundbreaking work in the field of neuroscience, specifically related to dopamine D3 receptors. With an impressive portfolio of 17 patents, her contributions have significantly advanced the understanding and treatment of psychiatric and neurological disorders.

Latest Patents

Among her latest patents, Newman has disclosed novel dopamine D3 receptor selective antagonists and partial agonists. These compounds exhibit high affinity and metabolic stability, which are crucial for effectively treating various psychiatric and neurological disorders. In addition to their therapeutic potential, these compounds serve as valuable research and diagnostic tools. One of her notable patents details methods for treating pain in patients, utilizing selective dopamine D3 receptor antagonists and partial agonists in conjunction with opioid analgesics. This innovative approach aims to mitigate the development of opioid dependence, thereby improving patient outcomes and enhancing the effectiveness of current Medication Assisted Treatment regimens for opioid use disorders.

Career Highlights

Newman's career has seen her collaborate with prestigious organizations, including the United States Department of Health and Human Services and the University of North Texas Health Science Center at Fort Worth. These affiliations have allowed her to contribute meaningfully to research and development within the biomedical field.

Collaborations

Throughout her career, Newman has worked alongside talented colleagues such as Jianjing Cao and Oluyomi M Okunola-Bakare. Their collaborative efforts showcase the importance of teamwork in advancing complex scientific research and innovative solutions.

Conclusion

Amy Hauck Newman’s contributions to neuroscience and pharmacology through her patents highlight her status as a leading inventor in her field. Her innovative approaches to addressing pain management and opioid dependence demonstrate her commitment to improving healthcare outcomes. As her research continues to evolve, the impact of her work will undoubtedly resonate across the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.